This is the last of the three-part podcast series, Keeping up with the Chemos on Mirvetuximab soravtansine.  Our multidisciplinary panel will discuss the challenges with patient monitoring while on Mirvetuximab soravtansine. The panel discusses personal clinical experiences and lessons learned.  When to dose adjust and hold or even discontinue Mirvetuximab soravtansine. Once again, the session ends with take home points for patient monitoring while on Mirvetuximab soravtansine.  

2022-2023 SGO Chemotherapy and Targeted Therapies Subcommittee Members and Moderators:
Tracilyn Hall, MD
Judith A. Smith, B.S., Pharm.D, BCOP, CPHQ

Speakers:
Julia Canestraro, OD, FAAO 
Karen Lyle, PA-C
Kathleen Moore, MD